ESG Inc. financial data

Symbol
PMIN on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
523 School House Rd, Kennett Square, Pennsylvania
State of incorporation
Nevada
Fiscal year end
December 31
Former names
PLASMA INNOVATIVE INC. (to 11/13/2023)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18.6 %
Debt-to-equity 139 %
Return On Equity -13.4 % +55%
Return On Assets -4.91 % +55.3%
Operating Margin -2.81 % +82.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9M shares +67.5%
Common Stock, Shares, Outstanding 25.9M shares +67.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 25.9K USD +67.5%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 25.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.38M USD +31.5%
Cost of Revenue 2.47M USD +68.5%
Research and Development Expense 131K USD +0.68%
General and Administrative Expense 318K USD +16.5%
Operating Income (Loss) -540K USD -791%
Nonoperating Income (Expense) -245K USD -101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -785K USD -331%
Net Income (Loss) Attributable to Parent -588K USD -313%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted -0.03 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 833K USD +5706%
Inventory, Net 718K USD
Assets, Current 2.15M USD +2790%
Property, Plant and Equipment, Net 769 USD -25.3%
Assets 25.3M USD +33573%
Accounts Payable, Current 1.3M USD +130160%
Liabilities, Current 1K USD -70.3%
Liabilities 1K USD -70.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -590K USD
Retained Earnings (Accumulated Deficit) -1.81M USD -2650%
Stockholders' Equity Attributable to Parent 8.78M USD +11720%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8M USD -12.2%
Liabilities and Equity 25.3M USD +33573%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 95K USD -80.9%
Net Cash Provided by (Used in) Financing Activities 138K USD
Net Cash Provided by (Used in) Investing Activities -40K USD +36.7%
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 25.9M shares +67.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 491K USD +37.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 833K USD +47.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 150K USD +5.58%
Deferred Tax Assets, Valuation Allowance 2.7M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 65 USD 0%
Payments to Acquire Property, Plant, and Equipment 63.2K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747K USD -653%
Property, Plant and Equipment, Gross 24.5M USD
Deferred Income Tax Expense (Benefit) -174K USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 2.7M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.2M USD +8843%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 17K USD -2.56%
Depreciation, Depletion and Amortization 453K USD -3.87%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%